Multi-Target Drugs for Neglected Diseases

E-ISSN： 1873-4286|22|21|3135-3163

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.21, 2016-06, pp. : 3135-3163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How to design multi-target drugs

By Korcsmáros Tamás Szalay Máté S Böde Csaba Kovács István A Csermely Péter

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 799-808

Informa Healthcare

Access to resources Recommend Favorite

Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders

By Geldenhuys Werner J Van der Schyf Cornelis J

Expert Opinion on Drug Discovery, Vol. 8, Iss. 2, 2013-02 ,pp. : 115-129

Informa Healthcare

Access to resources Recommend Favorite

Benzo- and Thienobenzo- Diazepines: Multi-target Drugs for CNS Disorders

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 8, 2015-06 ,pp. : 630-647

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 239-255

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) and its Cross-Talks with Topoisomerases: Challenges and Opportunities for Multi-Target Anticancer Drugs

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3226-3236

Bentham Science Publishers

Access to resources Recommend Favorite